Patent details

Basic Information

Publication number:

92912

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP959446923

Legal Status:

Expired

Application number:

92912

First applicant's nationality:

Procedural language:

French

Paediatric Extension

SPC Extension Filing Date:

19/09/2018

SPC Extension Agent Name:

OFFICE FREYLINGER S.A.

SPC Extension Status:

Granted

SPC Extension Grant Date:

18/01/2019

SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:

EU/1/15/1043 - Nucala - mépolizumab

Marketing Authorization Type:

Marketing Authorization Date:

07/12/2015

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

16/12/2015

First Marketing Authorization date:

07/12/2015

Grant date:

16/02/2016

Activation date:

22/12/2015

Publication date:

16/02/2016

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

22/12/2020

SPC Extension Expiration:

22/06/2021

Rejection date:

Withdrawal date:

Owner

From:

10/01/2018

 

 

Name:

GlaxoSmithKline LLC

Address:

251 Little Falls Drive, Wilmington, DE 19808, United States (US)

History of Owners

From:

16/12/2015

To:

10/01/2018

Name:

GLAXOSMITHKLINE LLC CORPORATION SERVICE COMPANY

Address:

2711 CENTREVILLE ROAD, WILMINGTON, DELAWARE 19808, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

16/12/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

COOK Richard M.

Address:

United States (US)

2

Name:

APPELBAUM Edward Robert

Address:

United States (US)

3

Name:

HOLMES Stephen Dudley

Address:

United Kingdom (GB)

4

Name:

AMES Robert S.

Address:

United States (US)

5

Name:

THEISEN Timothy Wayne

Address:

United States (US)

6

Name:

McMILLAN Lynette Jane

Address:

United States (US)

7

Name:

GROSS Mitchell Stuart

Address:

United States (US)

8

Name:

CHAIKEN Irwin M.

Address:

United States (US)

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2018/03

Publication date:

20/02/2018

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

SPCX1

Bulletin edition number:

2018/11

Publication date:

11/10/2018

Description:

Section G : Applications for extensions for pediatric use – I1E publication

3

Bulletin Heading:

SPCX2

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20180000011A

Date Registered:

10/01/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Changements de noms et d'adresses

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

GlaxoSmithKline LLC

Address:

251 Little Falls Drive, Wilmington, DE 19808, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

18/09/2019

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages
20/09/2018	Outgoing Correspondence	1
10/01/2018	Request For Change	4
19/09/2018	General Document	4
19/09/2018	General Document	36
20/09/2018	FNET_DC_FRONTPAGE	1
19/09/2018	General Document	1
19/09/2018	General Document	3
19/09/2018	Application Form	4
19/09/2018	General Document	1
18/01/2019	Certificate	1
18/01/2019	Publication	1
18/01/2019	Outgoing Correspondence	1
20/09/2018	Publication	1